Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 153

Quanterix quickens pace to IPO

The immunoassay instrument developer is targeting $57.5m in an offering that will provide exits for BioMerieux and Stratec Biomedical.

Nov 13, 2017

Sogou sucks up $585m in US offering

The Tencent and Sohu-backed search engine operator will go public in the US today, floating at the top of its range.

Nov 9, 2017

Aquantia acquires NYSE listing

The fabless semiconductor producer, which counts GlobalFoundries, Cisco, Intel, LSI and Xilinx as investors, has gone public in a $61.4m initial public offering.

Nov 8, 2017

InflaRx infiltrates public markets in $100m offering

The Germany-based, Ammann and Staidson-backed inflammatory disease therapy developer has floated in an initial public offering in the US.

Nov 8, 2017

Razer cleaves $528m from IPO

The Intel Capital-backed gaming equipment and accessories provider will float near the top of its range in Hong Kong.

Nov 7, 2017

Meituan-Dianping eyes 2018 IPO

Tencent, Priceline, Xiaomi, Fosun and Wanda are all in line for exits, as reports indicate the local services platform will seek $3bn in a US flotation.

Nov 7, 2017

Spero hits public markets with $77m IPO

The bacterial infections drug developer, based on research at Harvard Medical School, has gone public.

Nov 6, 2017

Spero hits public markets with $77m IPO

The bacterial infections drug developer, backed by Alphabet, Partners Healthcare, GlaxoSmithKline, Merck & Co and Lundbeck, has gone public.

Nov 6, 2017

Yixin gears up for $867m IPO

Tencent, Baidu, JD.com and BitAuto are all set to record exits, after the automotive financing platform filed to go public in Hong Kong.

Nov 6, 2017

Kaltura clears path for 2018 IPO

The Intel, Mitsui and Nokia-backed video software producer is talking to banks for an initial public offering tentatively planned for next year.

Nov 2, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here